Damian J. Green, MD
My life’s work has focused on developing new therapies for cancers of the blood and treating patients who are coping with those diseases. It’s so exciting to move discoveries from the research lab to the clinic in real time. One of the best parts of my job is being able to fine-tune care as we go, making it more effective and tolerable — so my patients can get back to doing what they love as soon as possible. It gives me hope that one day we can eradicate these cancers completely.
There are two important elements that inform everything I do. First, I believe it’s essential to create an authentic connection with you, understanding who you are outside your disease, what you wish for and what you value in life. Any recommendations I make about care are based on the interpersonal foundation we build together. Second, I’m committed to a team approach, partnering with other providers so we’re in agreement about what therapies will best serve your needs and goals.
Specialty: Medical Oncology
I am a hematologist-oncologist who treats patients with multiple myeloma and other cancers of the blood. I am a co-investigator on over 20 clinical trials and have published more than 75 scientific articles. In 2017, I was awarded a $3.2 million grant by the National Cancer Institute to test a new form of immunotherapy for multiple myeloma. I have also been a presenter at the annual conference for the American Society of Hematology.
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.
Cancer center among the first in the nation to offer the first approved CAR T-cell therapy for adults with multiple myeloma.
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.